Jiangsu Hengrui Pharmaceuticals Co.,Ltd Stock: price and insider trades · China
恒瑞医药
Jiangsu Hengrui Pharmaceuticals Co.,Ltd: what insiders have been doing
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, classified in the Health Care sector, is a listed company based in People's Republic of China, founded in 1997. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published a filing in the past twelve months. The most recent one dates from 2 September 2025.
Our records for Jiangsu Hengrui Pharmaceuticals Co.,Ltd go back to 2025, with no purchases and 2 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Jiangsu Hengrui Pharmaceuticals Co.,Ltd Strong Buy (bullish), based on 17 analysts. Average price target: CN¥70.92.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Jiangsu Hengrui Pharmaceuticals Co.,Ltd
恒瑞医药 is a Chinese company specializing in the healthcare and pharmaceutical sector. It is listed on the Shanghai Stock Exchange (XSHG).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
